Fowl Cholera in Poultry and Livestock: Etiology, Epidemiology, Clinical Presentation, Diagnostic Approaches, and Control Strategies

Introduction

Fowl cholera, also known as avian pasteurellosis, is a highly contagious bacterial disease affecting a wide range of domestic and wild avian species, as well as various mammalian livestock hosts. The disease is caused by the Gram-negative bacterium Pasteurella multocida and represents a significant economic burden to the poultry industry worldwide due to high morbidity, mortality, and production losses [1, 2]. In the context of veterinary medicine, fowl cholera bacterial infection is a primary differential diagnosis for acute septicemic diseases in poultry, turkeys, ducks, and other birds. This article provides an exhaustive, publication-grade review of the etiology, epidemiology, clinical presentation, diagnostic approaches, and control strategies for fowl cholera, with a focus on both avian and livestock hosts.

Etiology

The Causative Agent: Pasteurella multocida

Pasteurella multocida is a non-motile, facultatively anaerobic, Gram-negative coccobacillus belonging to the family Pasteurellaceae. The bacterium is characterized by its bipolar staining properties when exposed to Wright, Giemsa, or methylene blue stains, a feature that aids in preliminary microscopic identification. P. multocida is classified into five capsular serogroups (A, B, D, E, F) and 16 somatic lipopolysaccharide (LPS) serotypes based on the Heddleston scheme [2]. In avian hosts, capsular serogroups A and F are most commonly associated with fowl cholera, while serogroups B and E are more frequently isolated from ruminant livestock [3, 2].

Virulence Factors

The pathogenicity of P. multocida is mediated by a suite of virulence factors that facilitate colonization, immune evasion, and tissue damage. The polysaccharide capsule, particularly hyaluronic acid in serogroup A strains, is a critical antiphagocytic factor that protects the bacterium from opsonization and complement-mediated killing [4]. The stringent response, a bacterial stress response system mediated by the alarmone (p)ppGpp, has been identified as a negative regulator of hyaluronic acid capsule production, indicating a complex regulatory network governing virulence [4].

Additional virulence determinants include lipopolysaccharide (LPS), which contributes to endotoxic shock and tissue necrosis; fimbriae and pili (e.g., PtfA) that mediate adhesion to host epithelial cells; and filamentous hemagglutinin (FhaB2), which facilitates bacterial aggregation and biofilm formation [5, 6, 7]. Outer membrane proteins (OMPs) such as those solubilized by CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate) have been characterized as immunogenic targets and potential vaccine candidates [8]. The interplay of these factors determines the host range, tissue tropism, and severity of disease.

Genomic Diversity

Genomic profiling of P. multocida isolates has revealed substantial genetic diversity, with strains exhibiting distinct multilocus sequence types (STs) and pulsed-field gel electrophoresis (PFGE) patterns [1, 3, 2]. Whole-genome sequencing of isolates from poultry in Bangladesh has identified unique genomic features, including antimicrobial resistance genes and virulence-associated loci [1]. Similarly, genotypic evaluation of isolates from cattle and sheep using PFGE has demonstrated host-specific clustering, suggesting adaptation to different mammalian hosts [3]. The genomic diversity of P. multocida has direct implications for vaccine development and epidemiological tracking [2].

Epidemiology

Host Range and Susceptibility

Fowl cholera affects a broad spectrum of avian species, including chickens, turkeys, ducks, geese, and game birds. Turkeys are particularly susceptible, often experiencing acute outbreaks with high mortality [9]. Waterfowl, such as Muscovy ducks, are also highly vulnerable, and outbreaks in these species can serve as a source of infection for domestic poultry [10]. Among livestock, P. multocida is a primary pathogen in bovine respiratory disease complex (shipping fever) and causes pneumonic pasteurellosis in sheep and goats [3]. The bacterium can also infect swine, rabbits, and occasionally cats and dogs, though clinical disease in these species is less common.

Transmission and Risk Factors

Transmission of P. multocida occurs primarily through direct contact with infected birds or contaminated environments. The bacterium is shed in oral, nasal, and conjunctival secretions, as well as in feces. Fomites, including contaminated feed, water, equipment, and footwear, play a significant role in between-flock transmission. Carrier birds, which harbor the organism in their upper respiratory tract without showing clinical signs, are a major reservoir for recurrent outbreaks [9]. Stress factors such as overcrowding, poor ventilation, nutritional deficiencies, concurrent infections, and extreme weather conditions predispose flocks to clinical disease.

Geographic Distribution and Outbreak Patterns

Fowl cholera has a worldwide distribution, with outbreaks reported across all continents where poultry production occurs. In the United States, significant outbreaks have been documented in California multiplier breeder turkeys, with mortality rates ranging from 5% to 50% depending on the virulence of the strain and management practices [9]. In Japan, the first outbreak of fowl cholera in Muscovy ducks was characterized by acute mortality and isolation of P. multocida serogroup A [10]. In Bangladesh, genomic surveillance of P. multocida in ISA Brown chickens has highlighted the circulation of diverse strains with potential for zoonotic transmission [1]. The epidemiology of fowl cholera is further complicated by the existence of multiple serotypes and the ability of the bacterium to persist in the environment for extended periods.

Clinical Presentation

Peracute and Acute Forms

The peracute form of fowl cholera is characterized by sudden death in apparently healthy birds, often without premonitory signs. Mortality can reach 50% or higher within 24 to 48 hours of exposure [9]. In the acute form, affected birds exhibit fever (up to 44 degrees Celsius), depression, anorexia, ruffled feathers, and cyanosis of the comb and wattles. Respiratory signs, including dyspnea, rales, and mucoid nasal discharge, are common. Oral and nasal mucous membranes may be congested, and diarrhea, often greenish-yellow in color, is frequently observed. In laying hens, a sudden drop in egg production is a hallmark sign.

Chronic Form

Chronic fowl cholera typically develops in birds that survive the acute phase or in flocks with low-virulence strains. Clinical manifestations include localized infections such as swollen wattles (wattle edema), conjunctivitis, sinusitis, arthritis, and tenosynovitis. Torticollis (wry neck) may occur due to infection of the inner ear or meninges. Chronic respiratory disease with persistent coughing and nasal discharge can also be observed. In turkeys, chronic infections often present as lameness and joint swelling.

Lesions in Livestock

In mammalian livestock, P. multocida primarily causes respiratory disease. In cattle, acute pneumonic pasteurellosis is characterized by fever, depression, dyspnea, and a productive cough. Necropsy findings include fibrinous bronchopneumonia, pleuritis, and pulmonary edema. In sheep, the disease presents similarly, with cranioventral lung consolidation and pleural adhesions [3].

Pathology

Gross Lesions

Necropsy of birds that succumb to acute fowl cholera reveals characteristic gross lesions. Petechial and ecchymotic hemorrhages are observed on the epicardium, serosal surfaces of the abdominal organs, and in the musculature. The liver is typically enlarged, friable, and studded with multiple small, pale necrotic foci (miliary necrosis). The spleen is often swollen and congested. The lungs may be congested and edematous, and the air sacs may contain fibrinous exudate. In chronic cases, localized lesions include caseous abscesses in the wattles, joints, and tendon sheaths.

Histopathology

Histological examination of affected tissues reveals acute necrotizing inflammation. In the liver, multifocal coagulative necrosis with infiltration of heterophils and macrophages is observed. The spleen shows lymphoid depletion and fibrinoid necrosis of the splenic corpuscles. In the lungs, fibrinous bronchopneumonia with alveolar edema and heterophil infiltration is present. Vasculitis and thrombosis are common findings, reflecting the endotoxic nature of the infection.

Diagnostic Approaches

Clinical and Epidemiological Assessment

A presumptive diagnosis of fowl cholera is based on the history of acute mortality, characteristic clinical signs, and gross pathological lesions. Epidemiological data, including flock history, vaccination status, and recent stress events, are essential for differential diagnosis. Fowl cholera must be differentiated from other acute septicemic diseases such as avian influenza, Newcastle disease, salmonellosis (fowl typhoid and pullorum disease), and erysipelas.

Bacteriological Culture and Isolation

Definitive diagnosis relies on the isolation and identification of P. multocida from clinical specimens. Samples should be collected aseptically from the liver, spleen, heart blood, bone marrow, or localized lesions (e.g., wattle exudate). Swabs are plated onto blood agar or MacConkey agar and incubated at 37 degrees Celsius under microaerophilic conditions. P. multocida appears as small, grayish, non-hemolytic colonies on blood agar after 24 to 48 hours. The bacterium does not grow on MacConkey agar, a feature that aids in preliminary differentiation from Enterobacteriaceae. Identification is confirmed by Gram staining (Gram-negative coccobacilli with bipolar staining), positive catalase and oxidase reactions, and biochemical profiling using commercial identification systems.

Molecular Diagnostics

Molecular methods offer high sensitivity and specificity for the detection and characterization of P. multocida. Polymerase chain reaction (PCR) assays targeting species-specific genes, such as kmt1 (encoding a P. multocida-specific protein) or hyaD (capsular biosynthesis gene), are widely used for direct detection in clinical samples [1, 2]. Multiplex PCR assays can simultaneously identify the species and determine the capsular serogroup (A, B, D, E, F). Real-time quantitative PCR (qPCR) allows for quantification of bacterial load and is particularly useful for monitoring carrier birds.

Genotyping methods, including PFGE and multilocus sequence typing (MLST), are employed for epidemiological investigations to trace the source of outbreaks and identify transmission pathways [3, 2]. Whole-genome sequencing (WGS) provides the highest resolution for genomic characterization, enabling the detection of virulence genes, antimicrobial resistance determinants, and phylogenetic relationships [1, 2].

Serological Testing

Serological assays, such as enzyme-linked immunosorbent assays (ELISAs) and agglutination tests, can detect antibodies against P. multocida in serum or plasma. However, serology is of limited value for acute diagnosis due to the rapid progression of the disease. It is primarily used for flock-level surveillance and to assess vaccine-induced immunity.

Diagnostic Decision Tree

The following Mermaid diagram outlines a diagnostic workflow for fowl cholera in poultry.

flowchart TD
    A[Flock History: Acute Mortality, Clinical Signs], > B{Postmortem Examination}
    B, > C[Gross Lesions: Hepatic Necrosis, Petechiae, Pneumonia]
    C, > D[Collect Samples: Liver, Spleen, Heart Blood, Bone Marrow]
    D, > E[Gram Stain: Bipolar Gram-Negative Coccobacilli]
    E, > F[Culture on Blood Agar: Non-Hemolytic Colonies]
    F, > G[Biochemical Confirmation: Catalase +, Oxidase +, No Growth on MacConkey]
    G, > H{Confirmatory Testing}
    H, > I[Species-Specific PCR: kmt1 Gene]
    H, > J[Capsular PCR: hyaD, bcbD, etc.]
    H, > K[Genotyping: PFGE, MLST, WGS]
    I, > L[Definitive Diagnosis: Fowl Cholera]
    J, > L
    K, > L
    L, > M[Antimicrobial Susceptibility Testing]
    M, > N[Implement Control Measures: Treatment, Vaccination, Biosecurity]

Treatment

Antimicrobial Therapy

Prompt antimicrobial treatment is essential to reduce mortality in affected flocks. P. multocida is typically susceptible to a range of antibiotics, including penicillins, tetracyclines, sulfonamides, fluoroquinolones, and macrolides. However, antimicrobial resistance has been reported in various geographic regions, necessitating culture and susceptibility testing to guide therapy [1]. Commonly used antibiotics include oxytetracycline (administered in feed or water at 400-800 g/ton), sulfadimethoxine, and enrofloxacin. Treatment should be administered for a minimum of 5 to 7 days to prevent relapse. In severe outbreaks, parenteral administration of antibiotics (e.g., ceftiofur or tulathromycin) may be indicated for individual birds or small flocks.

Supportive Care

Supportive measures include improving ventilation, reducing stocking density, ensuring access to clean water and feed, and minimizing stress. Affected birds should be isolated, and dead birds should be removed promptly to reduce environmental contamination.

Control Strategies

Biosecurity

Strict biosecurity protocols are the cornerstone of fowl cholera prevention. These include controlling access to poultry houses, implementing all-in/all-out management, disinfecting equipment and vehicles, and preventing contact with wild birds and rodents. Carrier birds should be identified and culled to eliminate the reservoir of infection. In endemic areas, routine monitoring of sentinel birds can provide early warning of circulating P. multocida strains.

Vaccination

Vaccination is a key component of fowl cholera control programs. Both inactivated (bacterin) and live attenuated vaccines are available. Inactivated vaccines, typically containing multiple serotypes, induce humoral immunity and reduce mortality but may not prevent colonization or shedding. Live attenuated vaccines, such as the CU (Clemson University) strain, provide broader protection and are administered via drinking water or wing-web inoculation. The protective efficacy of live vaccines has been shown to be independent of LPS outer core structure, suggesting that other antigens, such as OMPs and fimbrial proteins, are critical for immunity [11].

Recombinant subunit vaccines targeting specific virulence factors have been investigated. Recombinant PtfA (type 4 fimbrial subunit) has demonstrated immunogenicity and protective efficacy in experimental trials [5]. Similarly, recombinant filamentous hemagglutinin (FhaB2) peptides have conferred protection against challenge in chickens [6]. The identification of CHAPS-soluble OMPs has provided additional targets for vaccine development [8]. Despite these advances, no single vaccine provides universal protection against all serotypes, and autogenous vaccines prepared from local isolates are often used in endemic regions.

Eradication and Depopulation

In the event of a severe outbreak, stamping out (depopulation of affected and contact flocks) followed by thorough cleaning and disinfection may be necessary to eliminate the pathogen. This approach is typically reserved for high-value breeder flocks or when the disease is newly introduced into a region.

Fowl Cholera in Hindi (फाउल कॉलरा)

For Hindi-speaking veterinary professionals and poultry farmers, fowl cholera is known as "फाउल कॉलरा" or "मुर्गी हैजा". The disease is caused by the bacterium पाश्चुरेला मल्टोसिडा (Pasteurella multocida). Clinical signs include sudden death, fever, greenish diarrhea, and cyanosis of the comb. Diagnosis is confirmed by bacterial culture and PCR. Control measures include vaccination, biosecurity, and antibiotic treatment. Understanding the local terminology and disease presentation is critical for effective communication and disease management in Hindi-speaking regions.

Conclusion

Fowl cholera remains a significant threat to poultry and livestock production worldwide. The causative agent, Pasteurella multocida, exhibits substantial genomic diversity and a complex array of virulence factors that enable it to infect a wide range of hosts. Rapid and accurate diagnosis, based on bacteriological culture, molecular methods, and genotyping, is essential for effective outbreak management. Control strategies rely on a combination of biosecurity, vaccination, and prudent antimicrobial use. Ongoing research into the genomic epidemiology and immunobiology of P. multocida will continue to inform the development of improved vaccines and diagnostic tools.

References

[1] Islam MA, Haque ME, Iftehimul M, et al. Genomic profiling of Pasteurella multocida strains isolated from ISA Brown (Gallus gallus domesticus) in Bangladesh. Microbiol Resour Announc. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41920836/

[2] Smith E, Miller E, Aguayo JM, et al. Genomic diversity and molecular epidemiology of Pasteurella multocida. PLoS One. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/33822782/

[3] Tabatabaei M, Janparvar A, Motamedifar M. Genotypic evaluation of Pasteurella multocida isolated from cattle and sheep by pulsed-field gel electrophoresis. Vet Res Forum. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37181852/

[4] Smallman TR, Williams GC, Harper M, et al. Genome-Wide Investigation of Pasteurella multocida Identifies the Stringent Response as a Negative Regulator of Hyaluronic Acid Capsule Production. Microbiol Spectr. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35404102/

[5] Gong Q, Qu N, Niu MF, et al. Evaluation of immunogenicity and protective efficacy of recombinant ptfA of avian Pasteurella multocida. Iran J Vet Res. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/27822232/

[6] Tatum FM, Tabatabai LB, Briggs RE. Protection against fowl cholera conferred by vaccination with recombinant Pasteurella multocida filamentous hemagglutinin peptides. Avian Dis. 2009. URL: https://pubmed.ncbi.nlm.nih.gov/19630220/

[7] Tatum FM, Yersin AG, Briggs RE. Construction and virulence of a Pasteurella multocida fhaB2 mutant in turkeys. Microb Pathog. 2005. URL: https://pubmed.ncbi.nlm.nih.gov/15998577/

[8] Tabatabai LB. Identification of Pasteurella multocida CHAPS-soluble outer membrane proteins. Avian Dis. 2008. URL: https://pubmed.ncbi.nlm.nih.gov/18459313/

[9] Campi TW, Carpenter TE, Hird DW, et al. Fowl cholera in California multiplier breeder turkeys: 1985-86. Avian Dis. 1990. URL: https://pubmed.ncbi.nlm.nih.gov/2282022/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[10] Nakamine M, Ohshiro M, Ameku Y, et al. The first outbreak of fowl cholera in Muscovy ducks (Cairina moschata) in Japan. J Vet Med Sci. 1992. URL: https://pubmed.ncbi.nlm.nih.gov/1477178/

[11] Harper M, John M, Edmunds M, et al. Protective efficacy afforded by live Pasteurella multocida vaccines in chickens is independent of lipopolysaccharide outer core structure. Vaccine. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/26892738/